Data as of Aug 29
| +0.06 / +0.21%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 30.00, with a high estimate of 33.00 and a low estimate of 27.00. The median estimate represents a +6.72% increase from the last price of 28.11.
The current consensus among 5 polled investment analysts is to Hold stock in Natus Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.